Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | JNK-IN-11 | 0.3 | uM | 2 | MCP-1 (MCAF) | 3544.5 | 42 | ||||
N2586 | IKK16 | 2.0 | uM | 2 | MCP-1 (MCAF) | 3658.0 | 60 | ||||
RA2159 | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 3627.0 | 77 | ||||
RA2159 | EO1428 | 1.0 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 5007.0 | 75 | |
RA2159 | PI103 | 0.1 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 2952.0 | 73 | |
RA2159 | Sigma A6730 | 3.0 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 2922.0 | 55 | |
RA2159 | JNK-IN-8 | 3.0 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 871.0 | 69 | |
RA2159 | JNK-IN-11 | 0.3 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 2870.0 | 94 | |
N2586 | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 8086.0 | 73 | ||||
N2586 | EO1428 | 1.0 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 7409.0 | 67 | |
N2586 | PI103 | 0.1 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 7548.0 | 65 | |
N2586 | Sigma A6730 | 3.0 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 7388.0 | 70 | |
N2586 | JNK-IN-8 | 3.0 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 2845.0 | 51 | |
N2586 | JNK-IN-11 | 0.3 | uM | EGF | 100 | ng/mL | 2 | MCP-1 (MCAF) | 36.5 | 80 | |
RA2159 | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 2713.0 | 88 | ||||
RA2159 | EO1428 | 1.0 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 3147.5 | 52 | |
RA2159 | PI103 | 0.1 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 2783.0 | 75 | |
RA2159 | Sigma A6730 | 3.0 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 3208.0 | 82 | |
RA2159 | JNK-IN-8 | 3.0 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 845.0 | 78 | |
RA2159 | JNK-IN-11 | 0.3 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 2777.5 | 76 | |
RA2159 | 2 | MCP-1 (MCAF) | 2966.0 | 86 | |||||||
N2586 | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 5794.0 | 85 | ||||
N2586 | EO1428 | 1.0 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 6158.5 | 78 | |
N2586 | PI103 | 0.1 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 5714.5 | 74 | |
N2586 | Sigma A6730 | 3.0 | uM | IGF-I | 100 | ug/mL | 2 | MCP-1 (MCAF) | 5869.0 | 75 |